COVID19, Sars-Cov-2
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Safety and Antibody Response of the Nasal COV2 Vaccine Against the SARS-CoV-2 Virus (NCT06851611) | Rokote Laboratories Finland Oy | 2025-01-21 |
Track COVID19, Sars-Cov-2 automatically
Every clearance here is in the API, with alerts when new ones post.